- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.06. | Merck, Gilead score in effort to develop the first weekly HIV pill | ||
| 09.06. | As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AstraZeneca and Daiichi rivals | ||
| 09.06. | AstraZeneca reprimanded over LinkedIn likes once again | ||
| 08.06. | ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes | ||
| 08.06. | With ADA in the books, analyst says Lilly is 'widening its lead' in the obesity race | ||
| 08.06. | 'Law & Order' star Mariska Hargitay teams up with BMS to investigate multiple myeloma research in awareness campaign | ||
| 08.06. | ADA: Novo's Wegovy pill reaches new GLP-1 patients with impressive 3M prescription milestone | ||
| 08.06. | Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi | ||
| 08.06. | Hikma earmarks $267M to expand pair of Ohio production sites, add 350 jobs | ||
| 05.06. | Takeda takes $2.5B legal charge after pay-for-delay verdict, swings to loss for '25 | ||
| 05.06. | Behind the headlines of ASCO 2026 | ||
| 04.06. | It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin | ||
| 04.06. | ADC Therapeutics' shares plummet after patient deaths in trial of Zynlonta | ||
| 04.06. | Axsome fends off generic competition to narcolepsy med Sunosi until 2040 | ||
| 04.06. | Medline earns FDA warning letter ire for repeated toxic bacteria problems | ||
| 03.06. | A patient-first shift in disease language and communication | ||
| 03.06. | Lilly, Boehringer to slash at least $1B each from planned investments in Germany | ||
| 03.06. | Coffee, racetracks, beaches and more coffee-inside the ASCO 2026 exhibit floor | ||
| 03.06. | Amid Miplyffa launch, Zevra CEO aims to foster EU-style Niemann-Pick market in US | ||
| 03.06. | With Cencora pact, Gilead looks to grow CAR-T treatment center network | ||
| 03.06. | FDA issues untitled letter after finding 'eye-catching graphics' in promotional emails | ||
| 03.06. | Neurotech launches new YouTube channel to spotlight patients' stories for rare eye disorder | ||
| 02.06. | Eli Lilly's ultimatum to hospitals: Send 340B claims data by June 8 or lose discounts | ||
| 02.06. | Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances | ||
| 02.06. | Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.